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APPL1- and RAB5-positive signaling endosomes
play a crucial role in the activation of AKT in response
to extracellular stimuli. Myosin VI (MYO6) and
two of its cargo adaptor proteins, GIPC and TOM1/
TOM1L2, localize to these peripheral endosomes
and mediate endosome association with cortical
actin filaments. Loss of MYO6 leads to the displace-
ment of these endosomes from the cell cortex and
accumulation in the perinuclear space. Depletion of
this myosin not only affects endosome positioning,
but also induces actin and lipid remodeling consis-
tent with endosomematuration, including accumula-
tion of F-actin and the endosomal lipid PI(3)P. These
processes acutely perturb endosome function, as
both AKT phosphorylation and RAC-dependent
membrane ruffling were markedly reduced by deple-
tion of either APPL1 or MYO6. These results place
MYO6 and its binding partners at a central nexus in
cellular signaling linking actin dynamics at the cell
surface and endosomal signaling in the cell cortex.
INTRODUCTION
The spatial distribution of cell signaling is a crucial aspect of cell
regulation and the sensing of extracellular environmental cues.
In particular, polarized cellular functions such as migration rely
on spatial regulation of RAC activation andmembrane trafficking
at the leading edge. Themechanisms underlying cell polarity and
directed cell migration have been extensively investigated, but
many questions still remain (Petrie et al., 2009). In particular,
spatial heterogeneity and structure in the endosomal system is
emerging as a key regulator of signaling processes (Sadowski
et al., 2009). For instance, the positioning of lysosomes is medi-
ated by motors linked to the microtubule cytoskeleton and has
long been shown to be important for their cellular function
(Heuser, 1989; Korolchuk et al., 2011). The distribution of many2088 Cell Reports 19, 2088–2101, June 6, 2017 ª 2017 The Author(s
This is an open access article under the CC BY license (http://creativeother classes of organelles is also correlated with the actin and
microtubule cytoskeletons, with interactions mediated by actin-
and tubulin-based molecular motors. In the case of signaling
endosomes, which are anchored to cortical actin near the cell
surface, this may enable the integration of external geometric
or mechanical cues with the endosomal system, although the
underlyingmechanisms have not been determined. Thus, under-
standing how endosomes interact with the actin cytoskeleton
and the consequences for their function is of crucial importance.
The role of actin dynamics at several steps along the endocytic
pathway has been given increasing attention. At the plasma
membrane, coated pits require actin polymerization to complete
scission when membrane tension is high, such as at the apical
surface of polarized cells (Boulant et al., 2011). At early sorting
endosomes, WASH-dependent actin polymerization regulates
the cargo sorting required for recycling and transport of recep-
tors to lysosomes (Duleh and Welch, 2010). However, the role
of the cortical actin network underneath the plasma membrane
in positioning and function of early signaling endosomes, which
connect clathrin-coated vesicles and EEA1-positive sorting en-
dosomes, is much less understood.
AKT (or Protein Kinase B) is a widely expressed serine/threo-
nine kinasewith crucial roles in the transduction ofmitogenic sig-
nals to the nucleus (Manning and Cantley, 2007) and in cell
migration and metastasis (Broussard et al., 2012; Irie et al.,
2005; Kim et al., 2001). Downstream signaling from AKT deter-
mines decision making during cell growth, division, and survival.
AKT is a major target of the PI-3 Kinase (PI3K) pathway and is
frequently hyper-activated in a range of cancers, receiving
much attention as a potential therapeutic target (Cheng et al.,
2005). The mechanism of AKT activation has been extensively
studied. In the canonical model, binding of extracellular growth
factors to receptor tyrosine kinases induces their activation via
conformation change and trans-phosphorylation (Lemmon and
Schlessinger, 2010). Phosphorylated receptors recruit adaptor
proteins such as GRB2 and SOS, which, in turn, recruit Ras
and PI3K to the plasma membrane. Activated PI3K generates
the phospholipid PI(3,4,5)P3, which is recognized and bound
by the PH domain of cytosolic AKT. This triggers a conforma-
tional change in AKT (Calleja et al., 2007), which is coupled to).
commons.org/licenses/by/4.0/).
phosphorylation at T308 by PDK1 and at the S473 site by the
mTORC2 complex (Ikenoue et al., 2008; Sarbassov et al., 2005).
However, AKT activation due to growth factor signaling not
only depends on interactions at the plasma membrane but can
also occur on endosomes (Wang et al., 2002). In particular,
signaling endosomes characterized by the presence of APPL1
(adaptor protein, phosphotyrosine interacting with PH domain,
and leucine zipper 1) have been shown to be required for AKT
activation in cultured cells and zebrafish (Schenck et al., 2008).
APPL1 binds directly to AKT (Mitsuuchi et al., 1999) and is
required for AKT activation in response to several extracellular
stimuli including insulin (Saito et al., 2007), nerve growth factor
(Lin et al., 2006; Varsano et al., 2006), and lysophosphatidic
acid (LPA) (Varsano et al., 2012).
MYO6 is an actin-based motor, which functions in a wide
range of important cellular processes, including endocytosis
(Buss et al., 2001), polarized secretion (Chibalina et al., 2010),
and autophagy (Tumbarello et al., 2012). It is unique in that it
is the only myosin known to move toward the minus end of actin
filaments (Wells et al., 1999). We have previously shown that
MYO6 localizes to EGF-stimulated membrane ruffles (Buss
et al., 1998) and is required for the formation of ruffling protru-
sions during wound healing and directed cell migration (Chiba-
lina et al., 2010). Furthermore, MYO6 is upregulated in numerous
cancers, where it has been suggested to promote cell migration
and invasion (Dunn et al., 2006) and thus represents a potential
therapeutic target. MYO6 has several splice isoforms, of which
the Large Insert isoform is preferentially expressed in polarized
epithelia and functions in clathrin-mediated endocytosis at the
apical surface (Buss et al., 2001). In this study, we focus on the
No Insert isoform of MYO6, which has been reported to localize
to signaling endosomes through its adaptor proteins GIPC and
TOM1/TOM1L2 (Tumbarello et al., 2012), although the function
of MYO6 and its binding partners on these endosomes is not
known.
In this study, we performed a detailed analysis on the role
of MYO6 at this specific class of signaling endosomes. We
demonstrate that MYO6 not only localizes to cortical APPL1
endosomes, but loss of MYO6 leads to perturbation of both
their localization and composition, which, in turn, impairs their
function in AKT activation. MYO6 depletion either by small
interfering RNA (siRNA) knockdown or in knockout mouse em-
bryonic fibroblasts (MEFs) or depletion of its binding partner
TOM1 leads to a reduction of AKT phosphorylation in response
to EGF stimulation. MYO6 is also present at high levels in EGF-
stimulated membrane ruffles and is required for their formation,
suggesting crucial links between actin cytoskeleton dynamics
at the plasma membrane and endosomal signaling in the cell
cortex.
RESULTS
MYO6-Positive APPL1 Endosomes Align along Cortical
Actin Filaments
We have previously reported that MYO6 and its cargo adaptor
proteins GIPC and TOM1/TOM1L2 are present on RAB5 and
APPL1-positive signaling endosomes (Tumbarello et al., 2012).
These endosomes are predominantly located in the actin-richcell cortex. To examine whether the distribution of APPL1
endosomes is linked to actin filaments, we used structured illu-
mination microscopy (SIM) to visualize APPL1 endosomes and
cortical actin filaments with high resolution in fixed HeLa cells
(Figure 1A). Our SIM images demonstrate that the vast majority
of APPL1 endosomes are positive for MYO6 (Figure S1A) and
align along actin filament bundles (Figure 1A). This arrangement
is in contrast to that of EEA1-positive endosomes, which are sur-
rounded by actin filament patches (Figure 1B) and do not coloc-
alize with MYO6 (Figure S1B). These results indicate that, while
both APPL1- and EEA1-positive endosomes are associated
with actin, the architecture and geometry of these interactions
are highly divergent.
Localization of APPL1 Endosomes to the Actin Cortex
Depends on MYO6
To assess the role of MYO6 in linking these signaling endosomes
to actin filaments, we treated cells with MYO6-targeting siRNA
(Figure 2A). Depletion of MYO6 by a smartpool of siRNA oligos
led to a dramatic accumulation of the RAB5- and APPL1-positive
endosomes in the perinuclear space (Figures 2A and 2B).
Depletion of endogenous MYO6 from endosomes was con-
firmed by western blotting and immunostaining with two rabbit
polyclonal antibodies (Figures S2A–S2E). We verified this
result using a single oligo targeting MYO6 (O7) and by pheno-
typic rescue following stable expression of the corresponding
siRNA-resistant GFP-MYO6 (Figures 2C and 2D). Accumulation
of RAB5 endosomes was also observed on depletion of the en-
dosomal MYO6-binding partner TOM1 (Figures S3A and S3B).
Perinuclear accumulation of RAB5 endosomes was accompa-
nied by a visible accumulation of F-actin (Figure 2E) and a slight
reduction of associated APPL1 (Figure 2A). These results sug-
gest that MYO6 promotes tethering of signaling endosomes to
cortical actin, effectively opposing long-range movement on
microtubules (Flores-Rodriguez et al., 2011) and associated
endosomal maturation (Driskell et al., 2007). To test this hypoth-
esis, we depleted MYO6 and incubated cells with the microtu-
bule depolymerizing agent nocodazole (Figures 2E and 2F).
While not rescuing peripheral endosome localization, nocoda-
zole prevented accumulation of endosomes in the perinuclear
space (Figures 2E and 2F), indicating a role for MYO6 in tethering
peripheral signaling endosomes.
Mutant Plus-End-Directed MYO6 Causes Clustering of
APPL1 Endosomes in the Cell Cortex
To further test the role of MYO6 in endosome positioning, we en-
gineered a mechanical mutant of MYO6, which moves toward
the plus end of actin filaments (Masters and Buss, 2017).
Replacement of the MYO6 lever arm with the lever arm of the
plus-end-directed motor myosin V (MYO5) has previously been
shown to direct MYO6 movement toward the plus end of actin
filaments in vitro (Park et al., 2007). In our recent study, we like-
wise replaced the lever arm (including the unique insert, IQ, and
lever arm extension) with the 6IQ domains fromMYO5 but retain
the motor domain and the cargo-binding tail of MYO6 to pre-
serve interaction with endogenous cargoes (Figure S4A). This
construct (termed MYO6+) still targets to APPL1 endosomes
but translocates these endosomes to the base of actin-richCell Reports 19, 2088–2101, June 6, 2017 2089
Figure 1. SIM of Endosomes and the Local Actin Network
HeLa cells were fixed and stained with (A) anti-APPL1 polyclonal or (B) anti-EEA1 monoclonal (detected with Alexa-647-labeled secondary antibodies), and
phalloidin conjugated with Alexa 568. Overlays of MYO6 and APPL1 (MYO6/APPL1; green and magenta, respectively) and APPL1 with phalloidin (APPL1/Phal;
magenta and cyan, respectively) are presented in (A) together with the respective overlays for EEA1 in (B). Scale bars in the first column, 5 mm, and in the second
column, 1 mm.protrusions at the plasma membrane resembling filopodia (Fig-
ure S4B). GFP-MYO6+ accumulated at both the tips of filopodia
(indicating that this mutant MYO6 indeed functions as a plus-
end-directed motor in cells) and on the APPL1 endosomes
jammed and clustered at the cell surface underneath the filopo-
dia. Staining for RAB5 confirmed a similar accumulation of
endosomes (Figures S4C and S4D). These results support our
finding that MYO6 plays a crucial role in positioning of signaling
endosomes.
Loss of MYO6 Leads to Accelerated Maturation of
APPL1 Endosomes
We next determined whether aberrant endosome localization
and positioning in MYO6-depleted cells causes any changes in
the biochemical composition of these vesicles. The forward traf-
ficking in the endocytic pathway and maturation of APPL1 endo-
somes into EEA1 endosomes is marked by the accumulation of
PI(3)P (Zoncu et al., 2009). We therefore first transfected cells
with the PI(3)P biosensor GFP-PX, which revealed a high density
of PI(3)P (Figure 3A) and EEA1 (Figure S5A) present on the endo-
somes that accumulated in the perinuclear space. This indicates
that the redistribution of signaling endosomes toward the cell
center, caused by loss of MYO6, leads to a maturation process
including accumulation of PI(3)P, potentially promoting detach-2090 Cell Reports 19, 2088–2101, June 6, 2017ment of APPL1 (consistent with the observed slightly weaker
perinuclear accumulation of APPL1 relative to RAB5). Expres-
sion of GFP-RAB5 leads to enhanced retention of APPL1 on
the displaced endosomes (Figure S5B), as previously suggested
(Zoncu et al., 2009). Loss of MYO6 is associated with an
accumulation of both PI(3)P (Figures 3B and 3C) and F-actin
(Figure 3D) in the perinuclear compartment. These experiments
show that MYO6 plays an important role in the spatiotemporal
distribution of signaling endosomes and their biochemical
characteristics.
AKT Activation Is Reduced in MYO6-Depleted Cells
The activation of the Ser/Thr kinase AKT downstream of growth
factor stimulation not only has been shown to take place at the
plasma membrane, but it continues after receptor endocytosis
on APPL1 signaling endosomes (Schenck et al., 2008). We
thus determined whether cellular responses to EGF stimulation
were perturbed by aberrant signaling endosome positioning af-
ter depletion of MYO6. Our results demonstrate that knockdown
of MYO6 in A549 cells significantly reduced AKT activation
following EGF stimulation, as determined by phosphorylation
of S473 but not T308 (Figures 4A and 4B). A similar reduction
in phosphorylated AKT (pAKT) was observed in primary mouse
fibroblasts derived from the MYO6 knockout mice (Snell’s
(legend on next page)
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Figure 3. Loss of MYO6 Leads to Lipid and Actin Remodeling of RAB5 Endosomes
(A) HeLa cells were treated with MYO6 targeting siRNA, transfected with GFP-PX, fixed, and stained with anti-RAB5 monoclonal antibody and phalloidin. An
overlay of PX, RAB5, and phalloidin (green, red, and blue, respectively) is presented, with the expanded region showing PX and RAB5 only. Scale bars, 10 mm.
(B) Box-and-whisker plot of Pearson’s correlation coefficients for colocalization of RAB5 with GFP-PX in experiments shown in (A).
(C) Box-and-whisker plot of relative enrichment of GFP-PX on RAB5 endosomes (calculated as described in the Experimental Procedures). Themean enrichment
in MYO6 KD cells is 1.26 (i.e., a 26% increase in density of PI3P).
(D) Box-and-whisker plot of Pearson’s correlation coefficients for colocalization of RAB5 with phalloidin in experiments shown in (A). Each distribution (in B–D)
contains over 60 cells from three experiments (p < 0.001). Scale bars, 10 mm.Waltzer - sv) (Figure 4C). Confirming the role of signaling endo-
somes in AKT activation, depletion of APPL1 (Figures S6A and
S6B) resulted in a marked reduction of AKT activation, as re-
ported previously (Schenck et al., 2008). MYO6 is recruited to
signaling endosomes via a number of binding partners including
TOM1 (Tumbarello et al., 2012). Consistent with this, depletion of
TOM1 also significantly reduced AKT phosphorylation following
EGF stimulation (Figures S6C and S6D). To analyze further the
role of the actin cytoskeleton and actin-based motors in AKT
activation, we depolymerized F-actin using latrunculin (LatA)
prior to EGF stimulation (Figures S6E and S6F). This led to a sig-Figure 2. MYO6 Is Required for Peripheral Localization of RAB5- and A
(A) HeLa cells were treatedwithMYO6 targeting siRNA, fixed and stainedwith anti
field microscopy. Scale bar, 10 mm.
(B) Quantification of experiments shown in (A) (more than 500 cells per condition
(C) HeLa cells either wild-type or stably expressing siRNA-resistant GFP-MYO6
(D) Quantification of experiments shown in (C) (more than 600 cells per condition
(E) HeLa cells were treated with MYO6 targeting siRNA, incubated with or without
Alexa-568-conjugated phalloidin.
(F) Quantification of experiments shown in (E) (more than 400 cells per condition
Images are representative of three independent experiments. Bar graphs repres
2092 Cell Reports 19, 2088–2101, June 6, 2017nificant reduction in phosphorylated AKT, as previously seen in
response to insulin (Eyster et al., 2005). However, actin is likely
to be required at many stages in EGF stimulation, for instance,
the local organization of receptors (Stabley et al., 2013), and
indeed less phosphorylated receptor was detected under LatA
treatment. To perturb the actin cytoskeleton in a more specific
way,we treated cellswith N-WASP targeting siRNA (Figure S6G),
which also caused a significant reduction in S473 pAKT, with lit-
tle effect on receptor phosphorylation (Figures S6H and S6I).
A similar result was obtained when treating with the N-WASP
inhibitor Wiskostatin (data not shown). In summary, these dataPPL1-Positive Signaling Endosomes
-RAB5monoclonal and anti-APPL1 polyclonal antibodies, and imaged bywide-
over three independent experiments, p < 0.001).
were treated with a single oligo (O7) targeting MYO6.
over three independent experiments, p < 0.001, **p < 0.01).
15 mM nocodazole for 1 hr, fixed, and stained with anti-RAB5 monoclonal and
over three independent experiments, p < 0.001).
ent mean ± SD. Scale bars, 20 mm.
A C
B
Figure 4. MYO6 Is Required for Full AKT Activation
(A) A549 cells were treated with control or MYO6 siRNA and stimulated with 20 ng/mL EGF for the indicated time periods. Lysates were generated and blotted
with the indicated antibodies. pTyr indicates a phosphorylated band at 250 kDa (corresponding to EGFR).
(B) Quantitation of A549 cell lysate blots for pT308 and pS473, showing an average of four independent experiments (MOCK cell lysates in white, MYO6 KD in
gray, errors SEM).
(C) Snell’s Waltzer fibroblasts (sv) were stimulated with platelet-derived growth factor (PDGF) and lysates examined by western blot.indicate that F-actin assembly and MYO6-motor functions are
crucial in regulating AKT activation.
MYO6 Is Not Required for PI3K Activation and AKT
Recruitment to the Plasma Membrane
To assess whether the reduction of AKT activation was caused
by processes occurring at the plasma membrane or on signaling
endosomes, cells were transfectedwithGFP-p85a, the regulato-
ry component of the PI3K complex. In unstimulated cells p85a
localized to focal adhesions (Figure 5A) (Chen and Guan,
1994), however, upon EGF stimulation, GFP-p85a translocated
from focal adhesions to puncta at or close to the plasma mem-
brane (Figure 5A) (Gillham et al., 1999). These puncta colocalized
with EGFR (Figures 5A and 5B), indicating that p85a was being
recruited into activated clusters of EGFR. No difference in therecruitment of p85a into these clusters was observed upon
knockdown of MYO6, strongly suggesting that MYO6 is not
required for recruitment and activation of the PI3K complex on
the plasma membrane.
Although our results demonstrate that p85a recruitment is not
regulated byMYO6, we next determined whether PI3K activity at
the plasma membrane was affected by loss of MYO6. For this
purpose, we designed a total internal reflection fluorescence
(TIRF) assay in which we transfected cells with the GFP-AKT-
PH domain, which binds to the 30-phosphoinositide products
of PI3K, PI(3,4)P2, and PI(3,4,5)P3. To account for the detectable
membrane area at the surface in the TIRF field, we used a
fluorescently tagged control plasmid targeted to the plasma
membrane, e.g., either PMT-RFP or Lyn-mCherry-FRB. Live
cells were imaged in TIRF mode (Figure 5C), and, on additionCell Reports 19, 2088–2101, June 6, 2017 2093
Figure 5. Loss of MYO6 Does Not Affect PI3K Activation or AKT Recruitment to the Plasma Membrane
(A) Cells were transfected with GFP-p85, fixed, and stained with anti-EGFR antibody. Images were acquired by confocal microscopy. Scale bars, 10 mm.
(B) Box-and-whisker plot of Pearson’s correlation coefficients for colocalization of GFP-p85 with EGFR in experiments shown in (A) (each distribution contains
60 cells from three independent experiments).
(C) Cells were transfected with GFP-AKT-PH, starved, and imaged by live-cell TIRF microscopy during addition of EGF (data shown are averages of more than
18 cells per condition from three independent experiments).
(D) Cells were transfectedwith GFP-AKT, starved, and imaged by live-cell TIRFmicroscopy during addition of EGF (data shown are averages ofmore than 15 cells
per condition from three independent experiments).
Error bars shown are SD.of EGF, a rapid and sustained recruitment of GFP-AKT-PH to the
membrane was observed over 4 min. On average, no significant
difference in recruitment was observed between mock and2094 Cell Reports 19, 2088–2101, June 6, 2017MYO6 knockdown cells, indicating no change in the production
of 30-phosphoinositides by PI3K. To complement this approach,
we repeated the experiment using GFP-tagged full-length AKT
(legend on next page)
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(Figure 5D). In this case, a peak in AKT fluorescence intensity
indicating maximal AKT recruitment to the plasma membrane
was observed after approximately 2 min. Similar to the AKT-
PH domain, no difference in recruitment dynamics of full-length
AKT was detectable, confirming that plasma membrane AKT
activation is unaffected by loss of MYO6.
MYO6 Is Required for Membrane Ruffling
Early RAB5-positive endosomes are important signaling plat-
forms for the activation of RAC, which is locally recycled back
to the plasmamembrane initiating a spatially restricted reorgani-
zation of the actin cortex and formation of plasma membrane
protrusions required for cell migration (Palamidessi et al.,
2008). As MYO6 is not only present in EGF-stimulated ruffles
(Buss et al., 1998) but is also required for directed cell migration
(Chibalina et al., 2010), it is conceivable that MYO6 may play a
role in endosomal RAC activation and/or trafficking and capture
of active RAC within ruffles. We thus next analyzed whether the
spatial and biochemical perturbations of peripheral RAB5 (i.e.,
APPL1)-positive signaling endosomes in MYO6-depleted cells
has an impact on RAC activation at the plasma membrane.
Consistent with this function, ablation of signaling endosomes
by siRNA-mediated knockdown of APPL1 prevented formation
of membrane ruffles following stimulation with EGF (Figure 6A).
We next analyzed the requirement of MYO6 for ruffle formation.
Downregulation of MYO6 by either siRNA (Figures 6B and S7A)
or CRISPR-mediated KO (Figure 6C) significantly perturbed
ruffle formation following EGF treatment. To understand how
RAC activity was affected, we transfected cells with YFP-RAC
(Figure 6D). We found that, in wild-type cells, RAC localized in
membrane ruffles as expected. When MYO6 was depleted,
RAC was no longer localized with peripheral actin (Figure 6D).
The defect in membrane ruffling was replicated by a treatment
with a single oligo (O7) and was rescued by stable expression
of siRNA-resistant GFP-MYO6 (Figures 6E and 6F). Overexpres-
sion of either the MYO6 tail or a rigor mutant of MYO6 (K157R),
which constitutively binds tightly to actin, prevented ruffle forma-
tion, while overexpression of wild-type MYO6 led to an increase
in EGF-stimulated membrane ruffling following starvation (Fig-
ures 6G and 6H). Conversely, expression of a mutant tail (RAL),
which is unable to bind to endosomes, has no effect on ruffle for-
mation (Figures 6G and 6H). Recruitment of MYO6 into ruffles at
the plasma membrane depends entirely on the motor domain asFigure 6. MYO6 Is Required for Ruffle Formation
(A) HeLa cells were treated with APPL1 targeting siRNA, stimulated with EGF for
panel) indicate the formation of membrane ruffles, which are not visible in cells la
(B) HeLa cells were transfected with GFP-AKT-PH, treated with MYO6 siRNA, an
(C) Wild-type andMYO6-CRISPR-KO HeLa cells were stimulated with 20 ng/mL E
bar, 20 mm.
(D) Cells were transfected with YFP-RAC, fixed, and stained with phalloidin-Al
anti-mouse antibodies).
(E) Expression of siRNA-resistant MYO6 rescues the defect in EGF-stimulated m
stained with phalloidin, and imaged in a wide-field microscope.
(F) Quantification of images in (E), with more than 300 cells per condition from tw
(G) HeLa cells were transfected with the indicated GFP-tagged constructs, stimu
and phalloidin. Scale bar, 20 mm.
(H) Quantification of experiments shown in (C), and (G), with more than 250 ce
mean ± SD.
2096 Cell Reports 19, 2088–2101, June 6, 2017constructs lacking the cargo-binding tail (Figure S7B) or with
cargo-binding sites mutated (Figure S7C) was still observed
in EGF-stimulated ruffles. Mutation of the motor domain at
site T405, which has been shown to moderately affect duty
ratio in vitro, did not affect recruitment of MYO6 into ruffles
(Figure S7D).
In summary, our data indicate that MYO6 regulates periph-
eral actin structures through endosomal positioning and struc-
tural organization, thus providing a link between growth factor
signaling and actin dynamics.
DISCUSSION
The actin cytoskeleton is emerging as a key regulator of the
endocytic pathway. The varied architecture and dynamics of
actin encountered by membranes at different steps in endoso-
mal trafficking may determine the trajectory and rate of sorting
and transport. In this study, we demonstrate that APPL1 endo-
somes, an early signaling compartment in the cell cortex that
receives input directly from the plasma membrane, align along
cortical actin filaments in the cell periphery, where they are
anchored by the motor protein MYO6. Loss of MYO6 leads to
accumulation of peripheral endosomes in the perinuclear space,
dependent on microtubules. In contrast, reversing the direction
of MYO6 leads to accumulation of APPL1 endosomes at the
cell surface and clustering at the base of filopodia. Displacing
endosomes toward the cell center leads to changes in both their
biochemical composition and signaling function. AKT activation
in response to EGF is significantly perturbed. Loss of MYO6 also
impairs actin reorganization at the plasma membrane and mem-
brane ruffle formation in response to growth factor stimulation,
which may be linked to the reported role of signaling endosomes
in RAC activation. These results indicate that spatial distribution
is a key regulator of endosomal function. Our data can be sum-
marized in the following model (Figure 7).
MYO6-Dependent Regulation of Endosomal Actin
Architecture
Dynamic actin rearrangements are required throughout the
endocytic pathway including for internalization at the plasma
membrane, cargo sorting, membrane fission, and endosome
distribution. Most published work has focused on actin rear-
rangements on early EEA1-positive sorting endosomes. These5 min, fixed, and stained with phalloidin. Yellow arrows (used throughout this
cking APPL1. Scale bar, 20 mm.
d stimulated with 100 ng/mL EGF for 5 min as in (A). Scale bar, 10 mm.
GF for 5 min, fixed, and stained with anti-MYO6 antibody and phalloidin. Scale
exa 568 and mouse anti-RAB5 (detected with Alexa-647-labeled secondary
embrane ruffling. Cells were stimulated with 100 ng/mL EGF for 5 min, fixed,
o independent experiments.
lated with 100 ng/mL EGF for 5 min, fixed, and stained with anti-GFP antibody
lls per condition from three independent experiments. Bar graphs represent
A B
Figure 7. Model of the Role of MYO6
in Signaling Endosome Positioning and
Function
(A) In wild-type cells, APPL1 endosomes sit on
peripheral actin filaments. On stimulation with
EGF, APPL1 recruits AKT promoting its activation.
Retention of endosomes in the periphery, depen-
dent on MYO6, further promotes AKT signaling.
Formation of membrane ruffles may depend on
RAC recycled from endosomes.
(B) When MYO6 is lost from APPL1 endosomes,
they translocate to the perinuclear space where
their lipid and protein composition is modified and
F-actin accumulates. In this state, they cannot
promote AKT activation or membrane ruffling in
response to EGF.EEA1 endosomes are coated by patches of actin, indicating
these distinct steps of the endocytic pathway receive very
different cues from the actin cytoskeleton, most likely via
WASH-mediated polymerization (Derivery et al., 2009). Actin
has been shown to regulate EEA1-positive endosome distribu-
tion, through ALIX (Cabezas et al., 2005) and Annexin A2
(Zobiack et al., 2003). By SIM, we show in this study that the
arrangement of APPL1 and EEA1 endosomes with respect to
actin is very different. Whereas EEA1 endosomes are often sur-
rounded by an actin ‘‘cloud,’’ the early signaling endosomes
align along actin filaments like ‘‘beads on a string.’’ The presence
of MYO6 on APPL1 (but not EEA1) vesicles may relate to the
character of actin to which they adhere, either by selectively
binding to specific pre-existing filaments or regulating actin
structure and polymerization once adhered. Selectivity for
certain types of filaments may be driven by the presence of
different isoforms of tropomyosin on different populations of
actin (Gunning et al., 2015). Recent work indicates that actin-
based motors may regulate their own actin tracks through a va-
riety of mechanisms. For instance, MYO6 has been shown in a
complex with the RACGEF DOCK7 (Majewski et al., 2012), while
MYO9B contains a RHOGAP in its own tail domain (Wirth et al.,
1996). Several studies have previously found a role for MYO6 in
regulating actin organization and dynamics in a diverse array of
biological functions including Drosophila spermatid individuali-
zation (Noguchi et al., 2006), melanosome biogenesis (Loube´ry
et al., 2012), and in cell-cell contacts (Mangold et al., 2011).
Endosome Distribution and Signaling Function
The spatial distribution of endosomes is closely linked to their
function within intracellular signaling cascades. Following recep-
tor internalization, nascent endosomes enter a unidirectional
maturation pathway, which finally leads to the accumulation of
early EEA1 endosomes, late endosomes, lysosomes, as well
as recycling endosomes in the perinuclear space. Disruption of
this pathway, e.g., caused by defects inMYO6-dependent endo-
some positioning, can lead to downstream effects, which may
explain our previously observed reduction in membrane tubules
emanating from the RAB11 recycling compartment (Chibalinaet al., 2007). The close proximity of most endosomal compart-
ments, except the APPL1 signaling endosomes, allows efficient
cargo delivery between these different compartments and leads
to the fast clearance of, for example, signaling receptors. A
recent study has identified RNF26 as a crucial regulator of archi-
tecture in the endosomal system by orchestrating a ubiquitin-
dependent vesicular tethering system in the perinuclear space
(Jongsma et al., 2016). It is therefore crucial to actively exclude
early signaling endosomes from the perinuclear space. The
MYO6-dependent tethering of APPL1 endosomes to the actin
cortex in the cell periphery stalls the endosomal maturation pro-
cess and allows continued signaling, before downstream cargo
processing. In this way MYO6 may act to oppose SQSTM1-
mediated vesicular tethering to the endoplasmic reticulum (ER)
(Jongsma et al., 2016), potentially constituting a cortical actin-
localized counterbalancing component of a ubiquitin-mediated
switch.
The Role of MYO6 and AKT in Cancer
Positioning of signaling endosomesmediated byMYO6 is crucial
for their function. We showed that loss of MYO6 acutely perturbs
phosphorylation of AKT on S473.We could find no defect in PI3K
or AKT recruitment dynamics at the plasma membrane following
EGF stimulation indicating that signaling endosome positioning
is crucial for AKT phosphorylation. S473 is phosphorylated by
TORC2 to promote cancer metastasis and invasion (Kim et al.,
2011). Our observation that MYO6 plays a role in AKT signaling
is an important finding that may have wider implications for the
role of MYO6 in cancer cells, since this motor is dramatically
overexpressed in prostate (Dunn et al., 2006) and ovarian (Yosh-
ida et al., 2004) cancers. Furthermore, AKT activation has a
crucial role in prostate cancer progression mainly driven by
accumulation of plasma membrane PI(3,4,5)P3 following muta-
tions in PTEN (Majumder and Sellers, 2005). However, how
AKT phosphorylation is coupled to the endosomal position is
not clear, and the subcellular localization and activity of
TORC2 remains mysterious. Reports suggest that TORC activity
is promoted by RAC1 (Saci et al., 2011). Thus, an intimate feed-
back may exist between RAC1 recruitment to endosomes andCell Reports 19, 2088–2101, June 6, 2017 2097
AKT phosphorylation. Displacement of signaling endosomes by
knockdown of either MYO6 or APPL1 may thus affect both AKT
activation and ruffle formation through RAC. EGFR can be traf-
ficked through APPL1-positive endosomes to promote AKT acti-
vation (Scita and Di Fiore, 2010). However, depletion of MYO6
does not appear to affect EGFR uptake and degradation (Tum-
barello et al., 2012), and the majority of EGFR may pass through
a parallel pathway to APPL1 en route to EEA1 endosomes
(Flores-Rodriguez et al., 2015). Thus, proximity of APPL1 endo-
somes to the plasma membrane and actin cortex may be
required for their function in addition to their content. Many ques-
tions remain regarding the role of APPL1 in AKT activation.
MYO6 in Membrane Protrusion Formation
RAB5 endosomes have previously been shown to mediate acti-
vation of RAC, thereby regulating actin dynamics at the plasma
membrane (Palamidessi et al., 2008). MYO6 is required for ruffle
formation at the plasma membrane, suggesting that control of
endosome position by MYO6 is a crucial step in the spatiotem-
poral regulation of RAC activity and thereby plasma membrane
dynamics. However, MYO6 not only regulates plasma mem-
brane protrusion formation, but is also present in membrane ruf-
fles (Figures 6 and S7), where it has been suggested to mediate
the polarized delivery of membrane into the leading edge by
ensuring fusion of vesicles at the site of ruffle formation (Bond
et al., 2011; Chibalina et al., 2010). Finally, at present we cannot
exclude that this motor plays an additional direct mechanistic
role in formation of plasma membrane ruffles by providing extra
protrusion force when anchored to the plasma membrane and
moving toward the minus end of actin filaments. In summary,
the association of MYO6 with membrane ruffles and with endo-
somes required for RAC activation as well as the secretory
pathway suggests that this motor may play a central role in coor-
dinating the formation of protrusions at the plasma membrane
with cellular signaling pathways.
EXPERIMENTAL PROCEDURES
Cell Lines, Antibodies, and Reagents
MEFs were derived from wild-type and Snells Waltzer (MYO6 knockout) mice
as described previously (Warner et al., 2003) and cultured in DMEM supple-
mented with 2 mM glutamine, 10% fetal bovine serum, and penicillin/strepto-
mycin. A549 cells were cultured in DMEM supplemented with Glutamax, 10%
fetal bovine serum, and penicillin/streptomycin at standard concentration.
HeLa cells were cultured in RPMI supplemented with high glucose, 10% fetal
bovine serum (FBS), and penicillin/streptomycin. CRISPR knockout HeLa cells
were generated as described (Brooks et al., 2017). siRNAs targeting MYO6
(smartpool and Oligo 7, J-0006355-07, sequence CAUUGUAUCUGGAG
AAUCA), APPL1 (smartpool), TOM1 (smartpool), and N-WASP (smartpool)
were obtained from Dharmacon (GE Healthcare). HeLa cells stably expressing
GFP-MYO6-siRes, which is resistant to MYO6-targeting Oligo 7, was
described previously (Tumbarello et al., 2012). PMT-RFP was a gift from
Thorsten Wohlund (Liu et al., 2007). Lyn-mCherry (Plasmid 38004, deposited
by Robin Irvine [Hammond et al., 2012]), GFP-AKT (Plasmid 39531
deposited by Julian Downward [Watton and Downward, 1999]), GFP-AKT-
PH (Plasmid 21218 deposited by Tobias Meyer [Raucher et al., 2000]), and
GFP-p85 (Plasmid 11499 deposited by Ronald Kahn was cloned into
pEGFP-C3) were obtained from Addgene. GFP-MYO6 refers to the No Insert
isoform (UniProtKB Q9UM54-5), and all amino acid designations align with
this sequence. GFP-MYO6 mutants were as follows: GFP-MYO6-tail
(Chibalina et al., 2010), GFP-MYO6-DPIP2 (Spudich et al., 2007); GFP-2098 Cell Reports 19, 2088–2101, June 6, 2017MYO6-K157R, GFP-MYO6-WLY, GFP-MYO6-RAL (Arden et al., 2016);
GFP-MYO6-DTail, GFP-MYO6-T405A and GFP-MYO6-T405E (Brooks et al.,
2017). GFP-MYO6-tail-RAL was generated by site-directed mutagenesis as
described (Arden et al., 2016). Antibodies were anti-RAB5 (mouse monoclonal
610282, BD Biosciences), anti-GFP monoclonal (ab1218, Abcam), anti-GFP
polyclonal (Invitrogen), Phalloidin-Alexa 568/647 (Invitrogen), anti-APPL1
(rabbit polyclonal, Santa Cruz Biotechnology), anti-EEA1 (mouse monoclonal
610456, BD Biosciences), anti-AKT (polyclonal, Cell Signaling Technol-
ogy), anti-AKT-T308 (polyclonal, Cell Signaling Technology), anti-AKT-S473
(polyclonal, Cell Signaling Technology), anti-EGFR (polyclonal, Santa Cruz),
MYO6 Ab2422 (developed in-house), MYO6 Ab3943 (developed in-house),
MYO6 Ab9907 (developed in-house), anti-TOM1/TOM1L2 (ab96320, Abcam),
and anti-N-WASP (polyclonal, Santa Cruz). All other reagents were from
Sigma-Aldrich (Spudich et al., 2007)
Western Blotting
Cells at 70%–80% confluency were rinsed once in ice-cold PBS and lysed in
ice-cold buffer containing 1% NP-40, 150 mM NaCl, 50 mM Tris, 1 mM EDTA,
phosphatase inhibitor cocktail (Roche, Sigma), and protease inhibitor cocktail
(Roche) for 5 min with scraping. Lysates were centrifuged at 20,000 3 g (4C)
for 15min, with the supernatant retained and either loaded on to 8%polyacryl-
amide gels (fabricated using the Bio-Rad system) of frozen at 80C for later
use. A two-sample t test was used to determine significance of experimental
data averaged over three experiments. Blots were quantified using ImageJ.
Total intensities for each band were extracted, background was subtracted,
and phosphorylation data were scaled by the total amount of AKT in each
lane. Multiple experiments were averaged by taking the phosphorylation signal
at the 5-min time point as a constant, with changes measured relative to this
time (set at 100%).
Immunofluorescence Sample Preparation
Cells were grown on no. 1.5 glass coverslips and following drug pre-treatment
and/or EGF stimulation were rinsed once in room temperature Dulbecco’s
PBS and fixed in 4% formaldehyde in Dulbecco’s PBS for 15min. On some oc-
casions a brief treatment (30 s) with 0.02% saponin was used prior to fixation
to remove cytosolic proteins. Fixed cells were washed in PBS, permeabilized
with 0.2% Triton in PBS for 5 min, washed again in PBS, and blocked in 1%
BSA for 1 hr. Primary antibodies were added for 1 hr, followed by three washes
in PBS for 5 min each. Coverslips were incubated with the appropriate
Alexa-Fluor-labeled secondary antibodies (Invitrogen) for 1 hr, followed by a
further three washes in PBS, rinsing in water, and mounting onto glass slides
using Prolong Gold (Invitrogen). For SIM, cells were grown on acid-washed,
no. 1.5, 18-mm square coverslips (high performance 170 ± 5 mm, Schott,
Germany). Following permeabilization with Triton, cells were quenched twice
with 0.2 M glycine for 5 min. Phalloidin was used at eight times the concentra-
tion of confocal experiments. Coverslips were mounted in Prolong Gold and
cured for 3 days at room temperature in the dark prior to imaging.
Microscopy
Wide-field microscopy was performed using an AxioImager 2 (Zeiss) employ-
ing either a 633 or 1003 objective. Confocal microscopy was performed with
an LSM 880 (Zeiss). SIM was performed using an Elyra superresolution micro-
scopy (Zeiss), using five rotations of the illumination pattern. Image processing
(reconstruction and channel alignment) was conducted using Zen Black edi-
tion (Zeiss), and 3D rendering was performed using Volocity (Perkin-Elmer).
TIRF Assay
Cells were transfected with GFP-AKT-PH and a membrane marker control,
either PMT-RFP or Lyn-mCherry. Cells were cultured in 35-mm glass-bottom
coverslip dishes (81158, ibidi) and transfected with the relevant constructs us-
ing Fugene (Promega). Media was replaced with live-cell imaging solution
(HEPES buffered, Invitrogen) andmounted on a TIRFmicroscope (Zeiss). Cells
were illuminated through a 1003 objective. Images were acquired every 10 s.
Intensities were recorded for 2 min prior to EGF addition. As a control, media
was added without EGF. To account for fluctuations in the amount of
membrane in the TIRF field, GFP-AKT-PH intensity was divided by relative
membrane marker intensity following background subtraction. The relative
recruitment of AKT-PH or AKT to themembranewas determined by dividing by










where BG denotes background (determined from an area of the image outside
the cell body.
Image Analysis and Statistics
Image processing was performed using ImageJ. The proportion of cells with
aberrant large perinuclear aggregates of RAB5 vesicles was scored manually
in each condition (with appropriate blinding controls). On average, ten fields of
view each containing 20 cells for each condition were used per experiment,
with each experiment repeated three times. Pearson’s correlation coefficient
was determined using the Coloc2 plug-in (in ImageJ)—images were back-
ground subtracted, and each cell was analyzed separately using a region of in-
terest (ROI). The enrichment of GFP-PX on endosomes was calculated as fol-
lows. RAB5 endosomes were segmented using the Threshold function in
ImageJ (the brightest 1%of pixels). The enrichment of GFP-PX on RAB5 endo-
somes was calculated as the ratio of endosomal GFP-PX fluorescence (using
an ROI corresponding to segmented RAB5 endosomes) to total GFP-PX fluo-
rescence in the cytoplasm, divided by the endosomal intensity of RAB5 (to ac-
count for increases in endosome density). For each experiment, the data were
scaled such that the average enrichment in the MOCK cells was 1 (in arbitrary
units). Statistics were determined using two sample t tests (Origin, OriginLab).
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